Protocol Ledger

Academic / Cooperative Group · Consolidated Sponsor Hub

City of Hope: Clinical Trials & FDA Approval Profile

City of Hope (Duarte, CA) sponsors 111 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 85 active protocols (53 recruiting now), 9 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)14.4%
Median Closed Enrollment vs National (145 pts)26 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for City of Hope
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)111
Active Pipeline (Recruiting Now)85 (53)
Completed vs Stopped Early9 / 16 (14.4%)
Median Closed Actual Enrollment26 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With City of Hope
Hospital Research SiteLocationShared Protocols
City of Hope National Medical CenterDuarte, CA105
City of Hope Orange CountyIrvine, CA21
City of Hope (South Pasadena)South Pasadena, CA9

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by City of Hope
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT05751434A Study on the Effects of Exercise Therapy on Signs of Prostate CancerPhase IIRECRUITING
NCT07218510Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic LymphoPhase IIRECRUITING
NCT07288034Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV NPhase IIRECRUITING
NCT03712202Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin LymphomaPhase IIACTIVE NOT RECRUITING

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for City of Hope across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the City of Hope Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI